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LETTER TO THE EDITOR
Plasma retinol, beta-carotene and vitamin E levels in relation to the
future risk of breast cancer
Sir - Russell and his colleagues present results in this issue
(Russell et al., 1988) that apparently differ from those
published in 1984 by Wald et al. (1984). The latter found
that women who subsequently developed breast cancer
(cases) had significantly lower vitamin E levels than matched
controls, but Russell and his colleagues found no significant
difference. The studies related to different women drawn
from the same population (but with sera collected about 10
years apart).
Since cases were compared to controls in each study,
systematic changes in sample or assay technique cannot
explain the discrepancy between the two studies. Early
cancer appears to affect serum vitamin E levels (Wald et al.,
1987), but in the study by Wald and his colleagues (1984),
the interval between serum collection and the diagnosis of
breast cancer was sufficiently long (mean 4.5 years) to make
this explanation unlikely.
Although when we reported our serum vitamin E and
breast cancer results in 1984, we believed that the quality of
the stored serum samples from cases and controls was
sufficiently sound to permit comparison of the concen-
trations of micronutrients in the samples, storage was only at
-20°C and no records were kept of the number of times the
samples had been withdrawn from storage. We cannot
therefore exclude the possibility that vitamin E degradation
may have occurred, and done so to a greater extent in the
samples from the cases than in those from the controls. Our
recently published negative results on serum vitamin E and
cancer in men (Wald et al., 1987) and the present results on
breast cancer reported by Russell and his colleagues
prompted us to re-examine this possibility. We therefore
reassayed the retinol, beta-carotene and vitamin E levels in
those of the original serum samples that were still available
and compared the current values with those in 1981 (and
reported in 1984) to obtain an indication of the extent to
which sample storage and handling between 1981 and 1986
affected the serum levels, and, by inference, how such
conditions may have affected them before. We also estimated
degradation in the complement component C3, which is
sensitive to sample handling and storage, by immunofixation
electrophoresis and densitometry.
The results of the vitamin assays are shown in Table I.
There were marked declines in levels of both vitamin E and
Table I Re-assay in 1986 of the 52 available serum samples from
control subjects that were assayed in 1981 and published by Wald
et al. (1984)
1981 1986
Mean s.d. Mean s.d.
Retinol (pgI) 466 122 448 132
f-carotene (pgP1) 59 89 3 6a
Vitamin E (mgP') 6.45 3.24 3.10 1.69a
aDifference between 1981 and 1986, P<0.001, sign test.
of beta-carotene between 1981 and 1986. There was also a
statistically significant difference in C3 degradation between
samples from cases and those from controls in 1986
(P<0.05); the mean percentages of degradation were 84.4%
in the 30 cases and 78.6% in the 52 controls. It is possible
that these results reflect differences that were present in
1981.
We conclude that the results reported by Wald et al.
(1984) may have been artefactual. This episode stresses the
importance of ensuring that biological samples used for
prospective studies are stored satisfactorily and that records,
especially of freezing and thawing, are kept to ensure the
comparability of cases and controls.
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